TTNP is the stock.
(Check the chart)
Priority review granted for the huge opiate addiction market.
MILLIONS are addicted to pain meds and illicit drugs.
TTNP has a 6 month slow release abuse proof implant for this epidemic.
Approval in April earns TTNP a $50 million milestone payment plus hefty royalties.
The stock of the year 2013.